SCHOTT Pharma AG & Co. KGaA Net Asset Quality Index
SCHOTT Pharma AG & Co. KGaA net asset quality index. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Net Asset Quality Index of 54.9% as of September 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.44 Billion minus total liabilities of €650.00 Million yields net assets of €792.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 1SXP operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Net asset quality index of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. This chart shows how SCHOTT Pharma AG & Co. KGaA's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2024, the index stands at 54.9%, representing net assets of €792.27 Million against total assets of €1.44 Billion EUR. See SCHOTT Pharma AG & Co. KGaA shareholders equity for net asset value and shareholders' equity analysis.
SCHOTT Pharma AG & Co. KGaA Net Asset Quality Index by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA net asset quality index by year from 2020 to 2024. The table below presents the year-by-year Net Asset Quality Index for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of SCHOTT Pharma AG & Co. KGaA.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.9% | €792.27 Million | €1.44 Billion | €650.00 Million | ▼ -1.3 pp |
| 2023 | 56.2% | €692.18 Million | €1.23 Billion | €539.65 Million | ▼ -3.1 pp |
| 2022 | 59.3% | €709.04 Million | €1.20 Billion | €487.46 Million | ▲ +2.6 pp |
| 2021 | 56.7% | €419.42 Million | €739.89 Million | €320.48 Million | ▲ +3.7 pp |
| 2020 | 53.0% | €315.66 Million | €596.02 Million | €280.36 Million | — |